Your 90-Day AR Analysis is complimentary - See your true collection gap.
Specialty RCM: Pain Management

Pain Management Billing Services
Built for Interventional Complexity

Interventional procedure coding, fluoroscopic guidance capture, RFA billing, urine drug testing codes, and prior authorization management, delivered as pain management billing services that close the revenue gaps driving your write-offs.

97.2%
Clean Claim Rate on Pain Management Submissions
<5%
Denial Rate, vs. 15-22% Specialty Average
14-17
Day AR Reduction for Pain Management Practices
400+
Certified Coders Including Interventional Pain Specialists
25+
Years in Subspecialty Medical Billing
All States Served
ASC and Office-Based Procedure Billing
Interventional Prior Authorization Management
98.4% HIPAA Compliance Rate

Where Pain Management Practices Lose Collectible Revenue

Pain management billing involves procedure-specific documentation requirements, mandatory fluoroscopy capture, payer-by-payer authorization rules, and drug testing coding complexity that general billing vendors mishandle systematically.

Fluoroscopic Guidance Not Captured as a Separate Billable Service

CPT 77003 and 77012 represent separately reimbursable fluoroscopic guidance services when performed during epidural and spinal injections. Vendors who bundle guidance into the injection code, or who fail to document imaging in the procedure note, leave a distinct billable unit uncollected on every interventional encounter.

Modifier 25 Omission on E/M and Procedure Same-Day Claims

When a significant evaluation and management visit precedes an interventional procedure on the same date, modifier 25 is required on the E/M code with independent supporting documentation. Without it, payers bundle the E/M into the procedure payment, generating a consistent, high-volume write-off in practices with heavy procedure days.

Interventional Prior Authorization Gaps and Expiration Failures

Epidural steroid injections, facet joint injections, radiofrequency ablation, and spinal cord stimulation trials require prior authorization from most commercial payers and Medicare Advantage plans. Expired authorizations, frequency limit overruns, and diagnosis mismatches between the authorization and the claim generate categorical denials on your highest-value procedures.

Urine Drug Testing Code Misclassification

Presumptive drug testing (G0477-G0483, CPT 80300-80304) and definitive drug testing (CPT 80320-80377) carry distinct reimbursement rates and documentation requirements based on methodology and number of drug classes analyzed. Applying the wrong category or failing to document clinical use of results is one of the most audited billing patterns in pain management.

RFA Bilateral and Multiple Level Billing Errors

Radiofrequency ablation billed at multiple spinal levels or bilaterally requires correct add-on code sequencing (CPT 64634, 64636) and documentation that each level was independently treated. Incorrect unit counts, missing bilateral modifiers, or inadequate level-specific documentation result in denials and post-payment audits from Medicare and commercial payers.

ASC vs. Office-Based Billing Framework Errors

Interventional pain procedures performed in an ambulatory surgery center require facility fee coding under the ASC payment system, separate from the professional fee claim. Applying office-based billing logic to ASC procedures, or submitting under the wrong place-of-service code, generates underpayments and claim rejections that accumulate undetected across billing cycles.

Pain Management CPT Codes Managed by MBC

Accurate pain management billing services depend on interventional-level coding knowledge across every procedure category. MBC applies the correct code, modifier, and documentation standard for each service.

Coding Rule: Epidural and spinal injection codes are anatomical-approach-specific. Interlaminar and transforaminal epidural codes are not interchangeable. Fluoroscopic guidance (CPT 77003) must be documented in the procedure note with imaging confirmation and billed separately from the injection code. Prior authorization is required by most commercial payers before procedure scheduling.
CPT CodeDescriptionKey Billing Requirement
62322Injection, interlaminar epidural, lumbar or sacral; without imaging guidanceDocument approach and spinal level; do not bill 77003 unless fluoroscopy was performed
62323Injection, interlaminar epidural, lumbar or sacral; with imaging guidanceIncludes fluoroscopic guidance; do not separately bill 77003
64483Transforaminal epidural injection, lumbar or sacral; single levelAuth required; document level and laterality; add-on 64484 for each additional level
64484Transforaminal epidural injection, each additional levelAdd-on to 64483; one unit per additional level treated
64490Injection, facet joint, cervical or thoracic; single levelAuth required; document joint level and approach; add-on 64491/64492 for additional levels
64493Injection, facet joint, lumbar or sacral; single levelAuth required; document medial branch or intra-articular approach; add-on 64494/64495
77003Fluoroscopic guidance for needle placementBill separately only when using 62322, 64483, 64490, or 64493; document imaging in note
Coding Rule: Radiofrequency ablation is coded by spinal region and number of levels treated. Each nerve level is a separately billable unit using the add-on codes. Bilateral procedures require modifier 50 or separate line entries per payer instructions. Documentation must identify each nerve treated, the electrode placement technique, and the lesioning parameters to support medical necessity.
CPT CodeDescriptionKey Billing Requirement
64633Destruction by neurolytic agent, facet joint nerve; cervical or thoracic, single levelAuth required; document level and laterality; imaging guidance required and included
64634Destruction, facet joint nerve, cervical or thoracic; each additional levelAdd-on to 64633; one unit per additional cervical or thoracic level
64635Destruction by neurolytic agent, facet joint nerve; lumbar or sacral, single levelAuth required; document nerve target, electrode parameters, and level confirmation
64636Destruction, facet joint nerve, lumbar or sacral; each additional levelAdd-on to 64635; units based on number of additional levels treated
Coding Rule: Spinal cord stimulation billing follows a trial-to-implant sequence. The trial (temporary electrode placement) must be billed and authorized separately from the permanent implant. CMS and commercial payers require documented trial success criteria before approving implant authorization. Programming visits are separately billable and cannot be bundled into the implant procedure.
CPT CodeDescriptionKey Billing Requirement
63650Percutaneous implantation of spinal neurostimulator electrode arraySeparate auth from implant; document trial duration and pain relief outcomes
63685Insertion of spinal neurostimulator pulse generator or receiverRequires documented successful trial; auth must cover implant specifically
63688Revision or removal of implanted spinal neurostimulator electrode arrayDocument reason for revision; prior auth required; separate from initial implant billing
95970Electronic analysis of implanted neurostimulator; without programmingSeparately billable at follow-up visits; document device parameters reviewed
95971Electronic analysis of implanted neurostimulator; with simple programmingDocument parameter changes; cannot be bundled with E/M on same date without modifier 25
Coding Rule: Urine drug testing in pain management is billed using presumptive codes for point-of-care or immunoassay screening and definitive codes for confirmatory laboratory testing. The number of drug classes analyzed determines the correct definitive code. CMS and OIG identify urine drug testing as a high-audit category in pain management; clinical documentation must establish medical necessity and demonstrate that results were reviewed and used in patient management decisions.
CodeDescriptionKey Billing Requirement
G0480Drug test, definitive; 1-7 drug classesDocument drug classes tested; clinical use of results must be in the note
G0481Drug test, definitive; 8-14 drug classesHigher reimbursement; confirm class count matches lab report before billing
G0482Drug test, definitive; 15-21 drug classesMost common level for comprehensive pain management UDT panels
G0483Drug test, definitive; 22 or more drug classesHighest tier; document medical necessity for expanded panel; audit risk is elevated
80300Drug screen, presumptive; any number of drug classes, any number of devicesPoint-of-care screening; document device used and clinical rationale
80302Drug screen, presumptive; single drug classUse when screening for one specific substance; document targeted drug and clinical basis
Coding Rule: The current CY Medicare Physician Fee Schedule introduced chronic pain management codes G3002 and G3003 for monthly management of chronic pain patients. These codes cannot be billed in the same month as Chronic Care Management (99490/99491) or Principal Care Management (99424/99425). On procedure days, E/M visits require modifier 25 with documentation that the visit was significant and separately identifiable from the pre-procedure assessment.
CPT CodeDescriptionKey Billing Requirement
99213-25Office E/M, moderate complexity, with modifier 25Separate documentation from procedure note; not bundled with injection or RFA
99214-25Office E/M, moderate-high complexity, with modifier 25Most common E/M level for pain management visits; Current MDM or time documentation required
G3002Chronic pain management, first 30 minutes per monthCannot bill same month as CCM (99490/99491) or PCM (99424/99425); document care plan
G3003Chronic pain management, each additional 15 minutes per monthAdd-on to G3002; document total time in care management activities for the month
99241-99245Office consultation for new pain management patientDocument reason for referral, history, examination, and MDM; payer-specific consultation rules apply

Why Pain Management Practices Choose MBC for Revenue Cycle Management

Pain management billing services require interventional procedure coding depth, payer-specific authorization infrastructure, and drug testing compliance expertise that general RCM vendors cannot deliver. MBC produces measurable outcomes across all three.

97.2%
Clean Claim Rate

Pre-submission audits validate procedure code selection, fluoroscopy capture, modifier application, and authorization status before every claim is transmitted.

95%
Net Collection Rate

Systematic denial follow-up, appeal management, and payer contract analysis maximize collections on every dollar of interventional pain revenue.

14-17
Day AR Reduction

Accelerated payment posting and proactive AR follow-up reduce days in accounts receivable across both office-based and ASC pain management billing environments.

$2.7B+
Revenue Processed Annually

MBC manages revenue cycle operations for ambulatory practices across 32+ specialties, applying enterprise-grade RCM infrastructure to pain management billing workflows.

Common Pain Management Billing Denials MBC Eliminates at the Claim Level

Interventional pain denial patterns are predictable and preventable. MBC applies payer-specific rule logic and authorization verification before submission so these denials never enter your AR queue.

CO-4 Missing Modifier

E/M visits billed on the same date as injections or RFA are denied when modifier 25 is absent, with payers treating the evaluation as included in the procedure reimbursement.

MBC fix: Modifier 25 validation is applied to every E/M claim sharing a date with an interventional procedure before submission.
CO-57 Prior Authorization Missing

Epidural, facet joint, and RFA claims denied when authorization was not obtained before the procedure date, or when the authorized diagnosis does not match the claim diagnosis.

MBC fix: Authorization is confirmed on file with diagnosis alignment verified against the payer record before every interventional procedure is scheduled.
CO-97 Bundled Service

Fluoroscopic guidance (CPT 77003) denied when billed alongside injection codes that already include imaging guidance, or when the procedure note does not document imaging separately from the injection narrative.

MBC fix: Fluoroscopy billing eligibility is verified at the code-pair level before submission, with documentation reviewed to confirm imaging is separately noted.
CO-50 Non-Covered or Frequency Exceeded

Facet joint injections and RFA procedures denied when the number of sessions in a plan year exceeds payer frequency limits, or when the treating diagnosis does not qualify under the payer's medical necessity criteria for interventional procedures.

MBC fix: Frequency tracking by procedure and payer is maintained per patient, with limit alerts triggered before a claim is submitted that would exceed coverage thresholds.
CO-11 Diagnosis Inconsistency

Interventional procedure claims denied when the ICD-10 diagnosis code does not support the procedure billed, or when the authorization was issued for a different diagnosis than what appears on the submitted claim.

MBC fix: ICD-10 code validation against procedure billed and authorization diagnosis is performed at the coding stage before every claim transmission.
CO-16 Missing Documentation

Urine drug testing and spinal cord stimulation claims rejected for missing medical necessity documentation, absent clinical use-of-results notation, or incomplete implant trial outcome records required by the payer before implant authorization approval.

MBC fix: Pre-submission documentation completeness review routes incomplete records to clinical staff before transmission, eliminating administrative rejections at the clearinghouse level.

MBC Pain Management Billing Services: End-to-End Workflow

1
Eligibility and Interventional Authorization

Coverage verified before each visit; prior authorization initiated per procedure type and payer before scheduling any interventional service.

2
Interventional Coding and Fluoroscopy Capture

Certified pain coders assign injection, RFA, and SCS CPT codes; fluoroscopic guidance billing eligibility confirmed; modifier 25 validated on procedure-day E/M claims.

3
Pre-Submission Claim Scrub

Bundling edits, frequency limit checks, authorization alignment, and UDT documentation completeness verified before every electronic submission.

4
Payment Posting and Underpayment Review

Payments posted within 24 hours; contractual underpayments on interventional procedure fee schedules flagged and corrected automatically.

5
Denial Management and AR Follow-Up

Denied claims routed to interventional pain-specific queues with procedure-appropriate appeal documentation, authorization reconsideration support, and UDT medical necessity addenda, tracked against payer filing deadlines.

What Pain Management Provider Groups Say About MBC

"Our RFA denial rate was above 24 percent before MBC. They identified that our previous vendor was not tracking bilateral procedure billing per payer instructions. Denials dropped below 5 percent within 60 days and we recovered over $180,000 in previously denied RFA claims through their appeal process."

Practice Administrator
Multi-Provider Interventional Pain Group, Texas

"We were systematically missing fluoroscopic guidance capture on our epidural claims. MBC identified this in the first billing audit and implemented a pre-submission documentation check. Our collections on injection procedures increased 21 percent in the first two billing cycles."

CFO
Pain Management Physician Group, Florida

"Urine drug testing was generating denials on nearly 30 percent of claims because our previous biller was applying presumptive codes to definitive testing. MBC corrected the code selection framework and brought our UDT collection rate above 93 percent within 90 days."

Physician Group Owner
Chronic Pain Management Practice, California

The Specialists Behind MBC Pain Management Billing Services

Pain management billing accuracy depends on the interventional coding depth and authorization infrastructure of the team executing it. MBC assigns subspecialty-trained personnel to every pain management account.

Interventional Pain Certified Medical Coders

CPC-certified coders with subspecialty pain management training in epidural and injection CPT sequencing, RFA add-on code billing, SCS trial-to-implant coding, and UDT presumptive versus definitive code selection. Current on the latest CMS Pain Management Fee Schedule changes.

Interventional Prior Authorization Specialists

Dedicated staff managing authorization requests for all interventional procedures, frequency limit tracking per payer, and diagnosis alignment verification between the authorization record and the submitted claim before every procedure date.

AR and Denial Resolution Analysts

Specialty-focused AR analysts managing pain management denial queues with procedure-appropriate appeal documentation, RFA bilateral billing reconsiderations, and UDT medical necessity support letters built per payer requirements.

Clinical Documentation Reviewers

Pre-submission reviewers who validate fluoroscopy documentation, procedure level specificity, UDT clinical use notation, and SCS trial outcome records against CPT coding requirements before claims are transmitted to payers.

Payer Contract and Credentialing Managers

Credentialing professionals maintaining provider enrollment across pain management payer panels, with contract fee schedule analysis for interventional procedure reimbursement rates and underpayment identification against contracted terms.

Dedicated Account Management

Each pain management practice is assigned a named account manager delivering monthly performance reporting, denial trend analysis by procedure category, and revenue variance reviews with direct escalation access for payer disputes.

Pain Management Billing Services: Common Questions

Pain management billing services include interventional procedure coding (epidurals, nerve blocks, facet joint injections, spinal cord stimulation), fluoroscopic guidance capture (CPT 77003), radiofrequency ablation billing, urine drug testing coding for both presumptive and definitive testing, prior authorization management for interventional procedures, E/M billing with modifier 25 on procedure days, and payer-specific denial management. MBC delivers all of these as standard components of its pain management RCM workflow, not as separately priced add-on services.
Pain management billing requires precise interventional procedure code selection based on anatomical approach and technique, mandatory fluoroscopic guidance capture as a separately billable service, distinction between presumptive and definitive urine drug testing codes, prior authorization from most payers for interventional procedures, and modifier 25 compliance on E/M visits on procedure days. CMS and commercial payers apply heightened scrutiny to pain management claims, and documentation errors result in categorical denials across high-value procedure categories that compound over billing cycles.
MBC manages prior authorization for all interventional pain procedures, including epidural steroid injections, facet joint injections, radiofrequency ablation, and spinal cord stimulation trials and implants. Authorization is initiated before the procedure is scheduled, with payer-specific clinical documentation packages built for each procedure type. MBC tracks authorization status, frequency limits, and expiration dates per patient and payer to prevent claim denials from expired or missing authorizations, the most common and preventable denial category in interventional pain billing.
Yes. MBC codes urine drug testing using the correct presumptive codes (G0477-G0483, CPT 80300-80304) and definitive codes (CPT 80320-80377 or G0480-G0483 for Medicare) based on testing methodology and number of drug classes analyzed. Definitive drug testing is one of the most frequently audited categories in pain management billing. MBC applies the correct code selection and ensures clinical documentation supports medical necessity and documents that results were reviewed and applied to patient management decisions before claims are submitted.
MBC maintains a denial rate under 5 percent across its pain management billing portfolio, compared to the specialty average of 15 to 22 percent for interventional pain practices. Pre-submission authorization verification, modifier compliance auditing, fluoroscopy documentation review, and frequency limit tracking eliminate the most common denial categories before claims reach payer adjudication. Practices transferring from general billing vendors typically see denial rates fall significantly within the first 60 days of MBC's onboarding audit process.
Yes. MBC supports billing for single-provider pain practices, multi-site physician groups, ambulatory surgery centers performing interventional pain procedures, and PE-backed pain management platforms. Each site is billed under the correct tax ID and NPI with payer-appropriate place-of-service codes. Multi-site groups receive consolidated reporting across locations with procedure-level performance breakdowns by provider and site, including denial trend analysis segmented by procedure category and payer.

Get Your Pain Management Revenue Audit

MBC's pain management billing specialists will review your current procedure coding patterns, denial trends, and authorization workflows to identify where your practice is generating uncaptured revenue. No commitment required.

C
CLARA
MBC Revenue Assistant · Online